Carcinogenesis, Vol. 23, No. 8, 1315-1320,
August 2002
© 2002 Oxford University Press
MOLECULAR EPIDEMIOLOGY AND CANCER PREVENTION |
Sex hormone-binding globulin polymorphisms in familial and sporadic breast cancer
1 Department of Biosciences at Novum, Karolinska Institute, SE-14157 Huddinge, Sweden,
2 Department of Tumor Biology, Centre of Oncology, Maria Sklodowska-Curie Institute, Gliwice, Poland,
3 Department of Pathology, Huddinge Hospital, SE-14186 Huddinge, Sweden,
4 I Clinics of Radiotherapy, Centre of Oncology, Maria Sklodowska-Curie Institute, Gliwice, Poland,
5 Department of Pathology, Centre of Oncology, Maria Sklodowska-Curie Institute, Gliwice, Poland and
6 Clinics of Chemotherapy, Centre of Oncology, Maria Sklodowska-Curie Institute, Gliwice, Poland
Ovarian steroids are one of the strongest risk factors for breast cancer. Sex hormone-binding globulin (SHBG) binds and transports sex steroids in the blood, regulating their bioavailable fraction and access to target cells. It can also inhibit the estradiol-induced proliferation of breast cancer cells through its membrane receptor. Three coding-region polymorphisms, which lead to an amino acid change, have been reported. We studied the influence of these three polymorphisms on breast cancer risk in three different populations: Polish familial breast cancer cases, 27% of them carrying a BRCA1/BRCA2 mutation, Nordic familial and sporadic breast cancer cases. The reported G to A polymorphism in exon 1 was not found in the 423 analyzed samples. Instead, we found a C to T transition causing an arg to cys amino acid change within the same codon in one Polish breast cancer patient and her daughter. Both of them were heterozygotes for the exon 8 G to A polymorphism as well. They were diagnosed for bilateral breast cancer and carried a BRCA1 mutation (5382insC). Analysis of the tumor samples showed that they had lost the wild-type allele both at exons 1 and 8 of the SHBG gene. Analysis of the other Polish samples showed no correlation of the exon 8 polymorphism to breast cancer, bilateral breast cancer, BRCA1/BRCA2 mutations or age at diagnosis. No association of the exon 8 polymorphism with breast cancer in the Nordic familial or sporadic cases was found. The C to T polymorphism located in exon 4 was rare in all the studied populations (overall allele frequency 0.011). However, in each of the study populations there was a trend for a lower variant allele frequency in cancer cases than in controls. Variant allele frequency in all the breast cancer cases was significantly lower than in all the controls (
2 = 5.27, P-value 0.02; odds ratio = 0.23, 95% confidence interval 0.05–0.84).
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  Y.-L. Low, A. M. Dunning, M. Dowsett, R. N. Luben, K.-T. Khaw, N. J. Wareham, and S. A. Bingham Implications of Gene-Environment Interaction in Studies of Gene Variants in Breast Cancer: An Example of Dietary Isoflavones and the D356N Polymorphism in the Sex Hormone-Binding Globulin Gene. Cancer Res., September 15, 2006; 66(18): 8980 - 8983. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Wagner, K. Hemminki, E. Grzybowska, R. Klaes, B. Burwinkel, P. Bugert, R. K. Schmutzler, B. Wappenschmidt, D. Butkiewicz, J. Pamula, et al. Polymorphisms in genes involved in GH1 release and their association with breast cancer risk Carcinogenesis, September 1, 2006; 27(9): 1867 - 1875. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K Wagner, K Hemminki, E Israelsson, E Grzybowska, R Klaes, B Chen, D Butkiewicz, J Pamula, W Pekala, and A Forsti Association of polymorphisms and haplotypes in the human growth hormone 1 (GH1) gene with breast cancer Endocr. Relat. Cancer, December 1, 2005; 12(4): 917 - 928. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Q. Jin, K. Hemminki, K. Enquist, P. Lenner, E. Grzybowska, R. Klaes, R. Henriksson, B. Chen, J. Pamula, W. Pekala, et al. Vascular Endothelial Growth Factor Polymorphisms in Relation to Breast Cancer Development and Prognosis Clin. Cancer Res., May 15, 2005; 11(10): 3647 - 3653. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Cui, X.-O. Shu, Q. Cai, F. Jin, J.-R. Cheng, H. Cai, Y.-T. Gao, and W. Zheng Association of Breast Cancer Risk with a Common Functional Polymorphism (Asp327Asn) in the Sex Hormone-Binding Globulin Gene Cancer Epidemiol. Biomarkers Prev., May 1, 2005; 14(5): 1096 - 1101. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. A. Haiman, S. E. Riley, M. L. Freedman, V. W. Setiawan, D. V. Conti, and L. Le Marchand Common Genetic Variation in the Sex Steroid Hormone-Binding Globulin (SHBG) Gene and Circulating SHBG Levels among Postmenopausal Women: The Multiethnic Cohort J. Clin. Endocrinol. Metab., April 1, 2005; 90(4): 2198 - 2204. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Burwinkel, M. Wirtenberger, R. Klaes, R. K. Schmutzler, E. Grzybowska, A. Forsti, B. Frank, J. L. Bermejo, P. Bugert, B. Wappenschmidt, et al. Association of NCOA3 Polymorphisms with Breast Cancer Risk Clin. Cancer Res., March 15, 2005; 11(6): 2169 - 2174. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Wagner, K. Hemminki, E. Grzybowska, R. Klaes, D. Butkiewicz, J. Pamula, W. Pekala, H. Zientek, D. Mielzynska, E. Siwinska, et al. The insulin-like growth factor-1 pathway mediator genes: SHC1 Met300Val shows a protective effect in breast cancer Carcinogenesis, December 1, 2004; 25(12): 2473 - 2478. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Q. Jin, K. Hemminki, E. Grzybowska, R. Klaes, M. Soderberg, and A. Forsti Re: Integrin {beta}3 Leu33Pro Homozygosity and Risk of Cancer J Natl Cancer Inst, February 4, 2004; 96(3): 234 - 235. [Full Text] [PDF]
|
|
|
|
|
|
S. E. Bojesen, A. Tybjaerg-Hansen, and B. G. Nordestgaard RESPONSE: Re: Integrin {beta}3 Leu33Pro Homozygosity and Risk of Cancer J Natl Cancer Inst, February 4, 2004; 96(3): 235 - 235. [Full Text] [PDF]
|
|
|
|
|
|
P. Cousin, L. Calemard-Michel, H. Lejeune, G. Raverot, N. Yessaad, A. Emptoz-Bonneton, Y. Morel, and M. Pugeat Influence of SHBG Gene Pentanucleotide TAAAA Repeat and D327N Polymorphism on Serum Sex Hormone-Binding Globulin Concentration in Hirsute Women J. Clin. Endocrinol. Metab., February 1, 2004; 89(2): 917 - 924. [Abstract] [Full Text] [PDF]
|
|